ЮМШОҚ ТЎҚИМА САРКОМАЛАРИНИНГ ЭПИДЕМИОЛОГИЯСИ
Keywords:
Юмшоқ тўқима саркомаси, касалланиш кўрсаткичи, ўлим кўрсаткичи, умумий яшовчанлик.Abstract
Мақолада чет эл муаллифларининг юмшоқ тўқима саркомаларининг долзарб муаммолари, касалланиш ва ўлим кўрсаткичлари ва ушбу касаллик билан ксалланган беморларнинг узоқ натижалари тўғрисида маълумотлар келтирилган. Юмшоқ тўқима саркомаси кам ўрганилган ва кўплаб илмий изланишлар талаб қиладиган касалликдир.
References
Nicolazzo C, Gradilone A. Significance of circulating tumor cells in soft tissue sarcoma. Anal Cell Pathol. 2015;
Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. WHO Lyon, IARC Press. 2013. Classification of tumours of soft tissue and bone. 4th edition.
National Comprehensive Cancer Network Soft Tissue Sarcoma. (ver. 2.2019). 2019.
Mertens F, Antonescu CR, Hohenberger P, Ladanyi M, Modena P, D’Incalci M, Casali PG, Aglietta M, Alvegård T. Translocation-related sarcomas. Semin Oncol. 2009;36(4):312–323.
Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CDM, Devesa SS. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: an analysis of 26,758 cases. Int J Cancer. 2006; 119 : 2922–2930.
Jo VY, Fletcher CDM: WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology 2014,46.
Hoefkens F, Dehandschutter C, Somville J, Meijnders P, Van Gestel D. Soft tissue sarcoma of the extremities: pending questions on surgery and radiotherapy. Radiat Oncol. 2016; 11:136. 10.1186/s13014-016-0668-9
Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM 3rd, Keedy V, Kim E, Koon H, et al.. Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018; 16:536–63. 10.6004/jnccn.2018.0025
Honoré C, Méeus P, Stoeckle E, Bonvalot S. Soft tissue sarcoma in France in 2015: Epidemiology, classification and organization of clinical care. J Visc Surg. 2015; 152:223–30. 10.1016/j.jviscsurg.2015.05.
Fletcher CDM. WHO Classification of Tumours of Soft Tissue and Bone. World Health Organization; 2013;
Chibon F, Aurias A, Coindre JM. Cancer Genomics. Dordrecht: Springer Netherlands; 2013. Sarcomas Genetics: From Point Mutation to Complex Karyotype, from Diagnosis to Therapies; pp. 429–52.
Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. WHO Lyon, IARC Press. 2013. Classification of tumours of soft tissue and bone. 4th edition.
National Comprehensive Cancer Network Soft Tissue Sarcoma. (ver. 2.2019). 2019.
Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Cli. 57:43–66. 2007.
Fernebro J, Bladström A, Rydholm A, Gustafson P, Olsson H, Engellau J and Nilbert M: Increased risk of malignancies in a population-based study of 818 soft-tissue sarcoma patients. Br J Cancer. 95:986–990. 2006.
Billingsley KG, Lewis JJ, Leung DH, Casper ES, Woodruff JM and Brennan MF: Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma. Cancer. 85:389–395. 1999.
Gronchi A, Casali PG, Mariani L, Miceli R, Fiore M, Lo Vullo S, Bertulli R, Collini P, Lozza L, Olmi P, et al: Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: A series of patients treated at a single institution. J Clin Oncol. 23:96–104. 2005.
A. de Juan Ferre, R. Alvarez Alvarez and other SEOM Clinical Guideline of management of soft-tissue sarcoma 2020.
Canadian Cancer Statistics. 2015. pp. 1–151
Kim HS, Nam CM, Jang S-Y, Choi SK, Han M, Kim S, Moneta MV, Lee SY, Cho JM, Novick D, Rha SY. Characteristics and treatment patterns of patients with advanced soft tissue sarcoma in iKorea. Cancer Research And Treatment: Official Journal of Korean Cancer Association. 2019;51:1380–1391.
Bessen T, Caughey GE, Shakib S, Potter JA, Reid J, Farshid G, Roder D, Neuhaus SJ. A population-based study of soft tissue sarcoma incidence and survival in Australia: an analysis of 26,970 cases. Cancer Epidemiol. 2019;63:101590.
Italiano A, Mathoulin-Pelissier S, Cesne AL, Terrier P, Bonvalot S, Collin F, Michels J-J, Blay J-Y, Coindre J-M, Bui B. Trends in survival for patients with metastatic soft-tissue sarcoma. Cancer. 2011;117:1049–1054.
WHO Classification of Tumours: Soft Tissue and Bone Tumours (2020). WHO Editorial Board WHO Classification of Tumours: Soft Tissue and Bone Tumours, 5th Ed. 978‐92-8324502‐5
Lyu HG, Haider AH, Landman AB, Raut CP (2019) The opportunities and shortcomings of using big data and national databases for sarcoma research. Cancer 125: 2926–2934
Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM 3rd, Keedy V, Kim E, Koon H, et al.. Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018; 16:536–63. 10.6004/jnccn.2018.0025
Popovich JR, Cassaro S. Cancer, Sarcoma. StatPearls. Treasure Island (FL): StatPearls Publishing StatPearls Publishing LLC; 2019
Singhi EK, Moore DC, Muslimani A. Metastatic Soft Tissue Sarcomas: A Review Of Treatment and New Pharmacotherapies. P T. 2018; 43:410–29.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019; 69:7–34. 10.3322/caac.21551
Trama A, Badalamenti G, Baldi GG, Brunello A, Caira M, Drove N, Marrari A, Palmerini E, Vincenzi B, Dei Tos AP et al (2019) Soft tissue sarcoma in Italy: from epidemiological data to clinical networking to improve patient care and outcomes. Cancer Epidemiol 59: 258–264
Bessen T, Caughey GE, Shakib S, Potter JA, Reid J, Farshid G, Roder D, Neuhaus SJ (2019) A population‐based study of soft tissue sarcoma incidence and survival in Australia: an analysis of 26,970 cases. Cancer Epidemiol 63: 101590
Wibmer C, Leithner A, Zielonke N, Sperl M, Windhager R. Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review. Ann Oncol. 2010;21:1106–11.
Casali PG, Blay JY; ESMO/CONTICANET/EUROBONET Consensus Panel of experts. Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and followup. Ann Oncol. 2010;21 Suppl 5:v198–203.
Schoffski P, Cornillie J, Wozniak A, Li H, Hompes D. Soft tissue sarcoma: an update on systemic treatment options for patients with advanced disease. Oncol Res Treat. 2014;37:355–62.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.
Stiller CA, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque MD, et al. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer. 2013;49:684–95.
Statistics Korea. Estimates of future population 2010-2060 [Internet]. Daejeon: Statistics Korea; 2011. [cited 2018 Dec 10].
Kang S, Kim HS, Choi ES, Han I. Incidence and treatment pattern of extremity soft tissue sarcoma in Korea, 2009-2011: a nationwide study based on the Health Insurance Review and Assessment Service database. Cancer Res Treat. 2015;47:575–82.
Йййййй
Ogura K, Higashi T, Kawai A. Statistics of soft-tissue sarcoma in Japan: report from the Bone and Soft Tissue Tumor Registry in Japan. J Orthop Sci. 2017;22:755–64.
Ray-Coquard I, Collard O, Ducimetiere F, Laramas M, Mercier F, Ladarre N, et al. Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS). BMC Cancer. 2017;17:111.
Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CD, Devesa SS. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases. Int J Cancer. 2006;119:2922–30.
Burningham Z, Hashibe M, Spector L, Schiffman JD. The epidemiology of sarcoma. Clin Sarcoma Res. 2012;2:14.
Bhatt N, Deady S, Gillis A, Bertuzzi A, Fabre A, Heffernan E, et al. Epidemiological study of soft-tissue sarcomas in Ireland. Cancer Med. 2016;5:129–35.
Francis M, Dennis N, Charman J, Lawrence G, Grimer R. Bone and soft tissue sarcomas: UK incidence and survival: 1996 to 2010. London: National Cancer Intelligence Network; 2013.
Gustafson P. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta Orthop Scand Suppl. 1994;259:1–31.
Yang L, Fang ZW, Fan ZF, Wang N, Yuan YN, Li HC, et al. An analysis of incidence trends and characteristics of soft tissue sarcoma in Beijing, 1999-2013. Zhonghua Zhong Liu Za Zhi. 2017;39:471–6.
Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Pineros M, et al. Cancer incidence in five continents. VolX. Lyon: International Agency for Research on Cancer; 2014.
Blay, Y. Using biology to guide the treatment of sarcomas and aggressive connective-tissue tumours / Y. Blay // Nat. Rev. Clin. Oncol. – 2018. – Vol.15. – № 7. – P.443–458.
Lee, A. Immunotherapy for Soft Tissue Sarcoma: Tomorrow Is Only a Day Away / A. Lee, P. Huang, R.P. DeMatteo, S.M. Pollack // Am. Soc. Clin. Oncol. Educ. Book. – 2016. – Vol.36. – P. 281–290.
Pang, A. Contemporary therapy for advanced soft-tissue sarcomas in adults / A. Pang, M.Carbini, R.G. Maki // JAMA Oncol. – 2016. – Vol. 2. – № 7. – P. 941–947
Siegel, R.L. Cancer statistics, 2018 / R.L. Siegel, K.D. Miller, A. Jemal // CA Cancer J. Clin.– 2018. – Vol. 68. – № 1. – P. 7–30.
Gino, I.K. Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations / I.K. Gino, J.S. Hu, W.W. Tseng // Ther. Adv. Med. Oncol. – 2017. – Vol. 9.– № 8. – P. 533–550.
Schupp, J. Targeting myeloid cells in the tumor sustaining microenvironment / J. Schupp, F.K. Krebs, N. Zimmer, E. Trzeciak, D. Schuppan, A. Tuettenberg // Cell Immunol. – 2017.DOI: 10.1016/j.cellimm.2017.10.013.
Каприн, А.Д. Злокачественные новообразования в России в 2016 году (заболеваемостьи смертность) / А.Д. Каприн, В.В. Старинский, Г.В. Петрова; под ред. А.Д. Каприна,143 В.В. Старинского, Г.В. Петровой. – М.: МНИОИ им. П.А. Герцена - филиал ФГБУ«НМИРЦ» Минздрава России, 2018. – 250 с.
Каприн, А.Д. Состояние онкологической помощи населению России в 2016 году / А.ДКаприн, В.В. Старинский, Г.В. Петрова; под ред. А.Д. Каприна, В.В. Старинского, Г.В.Петровой. – М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИРЦ» МинздраваРоссии, 2017. – 236 с.
РИО ва РИАТМ статистика маълумотлари.
